Viewing Study NCT02281760


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-03-05 @ 12:18 AM
Study NCT ID: NCT02281760
Status: COMPLETED
Last Update Posted: 2021-08-31
First Post: 2014-11-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
Sponsor: National Human Genome Research Institute (NHGRI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None BRAF V600E Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Histiocytosis View
None Non Langerhans Cell Histiocytosis View
None BRAF Inhibitor View